Technology
Myris Therapeutics
Recorded May 07, 2026
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
IQSTEL (NASDAQ: IQST) reaches over 600 telecom operators with access to approximately 2.3 billion end users around the world.
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
A revolutionary approach to treating autoimmune disease that’s rooted in precision medicine, rather than broad immunosuppression
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
A revolutionary approach to treating autoimmune disease that’s rooted in precision medicine, rather than broad immunosuppression
Building the digital infrastructure that is reshaping how intellectual property is valued, tracked, and monetized
Building the digital infrastructure that is reshaping how intellectual property is valued, tracked, and monetized
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins